Meeting
Abstract Number: 55
SHM Converge 2024
Background: As cannabis is legalized/decriminalized in more US jurisdictions, and social norms and perceptions around use change, many products for psychoactive, recreational use, and purported medical uses are available in edible and supplement formats. Rates of unintentional ingestion of cannabis products among children and adolescents have been described in the literature, but there is no […]
Abstract Number: 182
SHM Converge 2024
Background: Cannabinoid Hyperemesis Syndrome (CHS) is a rare condition first reported in adolescent patients in 2010. It is associated with episodic abdominal pain, emesis, and intractable nausea which resemble cyclical vomiting syndrome (CVS) in the setting of chronic use of cannabis. (5,12). Evidence of CHS treatment effectiveness in children is limited to case studies and […]